The results showed that in case 1 (Fig. 3A), the HER2 score was determined as zero by the conventional assay, but reevaluated as 2 + by the Nby-Aby test, and Nby-Aby also identified cancer cells that were not detected by the conventional assay. Here, ERBB2 is linked to cancer.